BR112015001038A2 - método e sistema para indicar hiperglicemia ou hipoglicemia para pessoas com diabetes - Google Patents

método e sistema para indicar hiperglicemia ou hipoglicemia para pessoas com diabetes

Info

Publication number
BR112015001038A2
BR112015001038A2 BR112015001038A BR112015001038A BR112015001038A2 BR 112015001038 A2 BR112015001038 A2 BR 112015001038A2 BR 112015001038 A BR112015001038 A BR 112015001038A BR 112015001038 A BR112015001038 A BR 112015001038A BR 112015001038 A2 BR112015001038 A2 BR 112015001038A2
Authority
BR
Brazil
Prior art keywords
diabetes
people
indicating
hypoglycaemia
hyperglycaemia
Prior art date
Application number
BR112015001038A
Other languages
English (en)
Inventor
Rodbard David
Wilson Howell Frances
Macleod Janice
Original Assignee
Lifescan Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lifescan Inc filed Critical Lifescan Inc
Publication of BR112015001038A2 publication Critical patent/BR112015001038A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
    • A61B5/14532—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue for measuring glucose, e.g. by tissue impedance measurement
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A61M5/142—Pressure infusion, e.g. using pumps
    • A61M5/14244—Pressure infusion, e.g. using pumps adapted to be carried by the patient, e.g. portable on the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A61M5/168—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
    • G16H20/10—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients
    • G16H20/17—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients delivered via infusion or injection
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H40/00—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices
    • G16H40/60—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices
    • G16H40/63—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices for local operation
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/20—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for computer-aided diagnosis, e.g. based on medical expert systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A61M5/142—Pressure infusion, e.g. using pumps
    • A61M2005/14208—Pressure infusion, e.g. using pumps with a programmable infusion control system, characterised by the infusion program
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/35—Communication
    • A61M2205/3546—Range
    • A61M2205/3553—Range remote, e.g. between patient's home and doctor's office
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/35—Communication
    • A61M2205/3546—Range
    • A61M2205/3569—Range sublocal, e.g. between console and disposable
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/35—Communication
    • A61M2205/3576—Communication with non implanted data transmission devices, e.g. using external transmitter or receiver
    • A61M2205/3584—Communication with non implanted data transmission devices, e.g. using external transmitter or receiver using modem, internet or bluetooth
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/35—Communication
    • A61M2205/3576—Communication with non implanted data transmission devices, e.g. using external transmitter or receiver
    • A61M2205/3592—Communication with non implanted data transmission devices, e.g. using external transmitter or receiver using telemetric means, e.g. radio or optical transmission

Abstract

resumo patente de invenção: "método e sistema para indicar hiperglicemia ou hipoglicemia para pessoas com diabetes". a presente invenção refere-se a vários métodos e sistemas para gerenciar a diabetes de um indivíduo com o uso dos dados relacionados aos padrões para fornecer uma visão de como as atividades diárias de um paciente impactam o controle glicêmico do indivíduo. tais padrões auxiliam a identificar áreas muito específicas de excursões glicêmicas, possibilitam que os pacientes e hcps identifiquem com mais facilidade os padrões de hipoglicemia e hiperglicemia para realizar as etapas para otimizar o controle glicêmico da pessoa com diabetes.
BR112015001038A 2012-07-19 2013-07-18 método e sistema para indicar hiperglicemia ou hipoglicemia para pessoas com diabetes BR112015001038A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US13/553,655 US20140024907A1 (en) 2012-07-19 2012-07-19 Method and system to indicate hyperglycemia or hypoglycemia for people with diabetes
PCT/US2013/051113 WO2014015160A2 (en) 2012-07-19 2013-07-18 Method and system to indicate hyperglycemia or hypoglycemia for people with diabetes

Publications (1)

Publication Number Publication Date
BR112015001038A2 true BR112015001038A2 (pt) 2017-06-27

Family

ID=49947119

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112015001038A BR112015001038A2 (pt) 2012-07-19 2013-07-18 método e sistema para indicar hiperglicemia ou hipoglicemia para pessoas com diabetes

Country Status (13)

Country Link
US (1) US20140024907A1 (pt)
EP (1) EP2874541A4 (pt)
JP (1) JP2015530889A (pt)
KR (1) KR20150036706A (pt)
CN (1) CN104470430A (pt)
AU (1) AU2013292522A1 (pt)
BR (1) BR112015001038A2 (pt)
CA (1) CA2879324A1 (pt)
HK (1) HK1209996A1 (pt)
IN (1) IN2015DN00397A (pt)
RU (1) RU2015105626A (pt)
TW (1) TW201417774A (pt)
WO (1) WO2014015160A2 (pt)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014036177A1 (en) * 2012-08-30 2014-03-06 Abbott Diabetes Care Inc. Optimizing medication dosage based on analyte sensor data
US9233204B2 (en) 2014-01-31 2016-01-12 Aseko, Inc. Insulin management
US9486580B2 (en) 2014-01-31 2016-11-08 Aseko, Inc. Insulin management
US11081226B2 (en) 2014-10-27 2021-08-03 Aseko, Inc. Method and controller for administering recommended insulin dosages to a patient
EP3050023B1 (en) 2014-10-27 2021-08-25 Aseko, Inc. Subcutaneous outpatient management
WO2017011346A1 (en) * 2015-07-10 2017-01-19 Abbott Diabetes Care Inc. System, device and method of dynamic glucose profile response to physiological parameters
CA2993275C (en) 2015-08-20 2022-06-21 Aseko, Inc. Diabetes management therapy advisor
FR3047098B1 (fr) * 2016-01-21 2018-05-25 Voluntis Gestion de l'equilibre glycemique d'un patient diabetique
WO2017132663A1 (en) * 2016-01-29 2017-08-03 Patek Stephen D Method, system, and computer readable medium for virtualization of a continuous glucose monitoring trace
CN108283486B (zh) * 2017-01-09 2021-04-09 腾讯科技（深圳）有限公司 测量数据的处理方法及装置
TWI668664B (zh) * 2017-01-16 2019-08-11 華廣生技股份有限公司 Method for dynamically analyzing blood sugar level, system thereof and computer program product
CN108335750B (zh) * 2017-01-20 2022-08-09 华广生技股份有限公司 动态分析血糖值的方法、系统与计算机存储介质
EP3361402A1 (en) * 2017-02-14 2018-08-15 Roche Diabetes Care GmbH A computer-implemented method and a portable device for analyzing glucose monitoring data indicative of a glucose level in a bodily fluid, and a computer program product
EP3600014A4 (en) * 2017-03-21 2020-10-21 Abbott Diabetes Care Inc. METHODS, DEVICES AND SYSTEM FOR PROVIDING DIAGNOSIS AND THERAPY FOR DIABETIC CONDITION
USD853583S1 (en) 2017-03-29 2019-07-09 Becton, Dickinson And Company Hand-held device housing
TWI678630B (zh) * 2018-01-16 2019-12-01 中央研究院 非侵入式估測hba1c與血糖值之系統與方法
WO2020127137A1 (en) * 2018-12-19 2020-06-25 Sanofi Pattern recognition engine for blood glucose measurements
WO2021011697A1 (en) 2019-07-16 2021-01-21 Beta Bionics, Inc. Blood glucose control system
WO2022140204A1 (en) * 2020-12-21 2022-06-30 Beta Bionics, Inc. Medicament pumps and control systems thereof
US11278661B2 (en) 2020-03-10 2022-03-22 Beta Bionics, Inc. Infusion system and components thereof
CN111653337A (zh) * 2020-05-19 2020-09-11 曲靖师范学院 一种血糖设备控制方法、系统、装置、存储介质、程序
US20220199218A1 (en) 2020-12-07 2022-06-23 Beta Bionics, Inc. Ambulatory medicament pump with integrated medicament ordering interface
US11688501B2 (en) 2020-12-07 2023-06-27 Beta Bionics, Inc. Ambulatory medicament pump with safe access control
US20220265143A1 (en) * 2020-12-07 2022-08-25 Beta Bionics, Inc. Ambulatory medicament pumps with selective alarm muting
US11497852B2 (en) * 2020-12-21 2022-11-15 Beta Bionics, Inc. Ambulatory medicament device with power saving mode

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001072208A2 (en) * 2000-03-29 2001-10-04 University Of Virginia Patent Foundation Method, system, and computer program product for the evaluation of glycemic control in diabetes from self-monitoring data
US7824333B2 (en) * 2006-03-31 2010-11-02 Lifescan, Inc. Diabetes management methods and systems
US8758245B2 (en) * 2007-03-20 2014-06-24 Lifescan, Inc. Systems and methods for pattern recognition in diabetes management
US20090240127A1 (en) * 2008-03-20 2009-09-24 Lifescan, Inc. Methods of determining pre or post meal time slots or intervals in diabetes management
EP2354990A1 (en) * 2010-02-03 2011-08-10 Clifton A. Alferness System and method for actively managing type 1 diabetes mellitus on a personalized basis
US8206340B2 (en) * 2010-08-18 2012-06-26 Thuban, Inc. Integrated glucose monitor and insulin injection pen with automatic emergency notification

Also Published As

Publication number Publication date
TW201417774A (zh) 2014-05-16
CN104470430A (zh) 2015-03-25
US20140024907A1 (en) 2014-01-23
WO2014015160A2 (en) 2014-01-23
CA2879324A1 (en) 2014-01-23
WO2014015160A3 (en) 2015-04-30
HK1209996A1 (en) 2016-04-15
EP2874541A2 (en) 2015-05-27
IN2015DN00397A (pt) 2015-06-19
RU2015105626A (ru) 2016-09-10
EP2874541A4 (en) 2016-06-08
AU2013292522A1 (en) 2015-03-05
KR20150036706A (ko) 2015-04-07
JP2015530889A (ja) 2015-10-29

Similar Documents

Publication Publication Date Title
BR112015001038A2 (pt) método e sistema para indicar hiperglicemia ou hipoglicemia para pessoas com diabetes
BR112015005519A2 (pt) método e sistema para indicar os impactos glicêmicos dos comandos da bomba de infusão de insulina
AU2019268205A1 (en) Analysis of glucose median, variability, and hypoglycemia risk for therapy guidance
BR112013010023A2 (pt) algoritimo aperfeiçoado para a detecção de diabetes
BR112014018433A8 (pt) Métodos para determinar o período circadiano em um indivíduo humano e um tau de um paciente, para tratar um paciente humano, para fornecer informação relativa a um ritmo circadiano do paciente, e para converter dados da concentração de melatonina ou substituto de melantonina nos dados do ritmo circadiano, sistema, e, meio de armazenagem legível por computador
BR112016008676A8 (pt) sistemas para avaliar ou monitorar uma incapacidade ou capacidade de desenvolvimento; e métodos para a identificação de uma alteração na fixação visual de um indivíduo no tempo
BR112013020724A2 (pt) vestimenta para uso por um ser vivo, em que a vestimenta é adaptada para uso para fornecer um mapa da atividade elétrica, sistema, método e programa de computador para fornercer um mapa de atividade elétrica do coração de um ser vivo por meio de sinais elétricos do coração obtidos por uma série de eletrodos da superfície que são dispostos sobre uma superfície externa do ser vivo
BR112014027594A2 (pt) dispositivo para apoiar uma mudança de comportamento de uma pessoa, método para apoiar uma mudança de comportamento de uma pessoa utilizando um dispositivo e programa de computador
BR112014027571A2 (pt) métodos para o tratamento de retinopatia diabética e outras doenças oftalmológicas
BR112013021153A2 (pt) dispositivo e métodos de rastreamento ocular de fotorrefração
BR112013024574A2 (pt) polipeptídeo, uso, método de tratamento de indivíduos portadores de doenças e método de tratamento de indivíduos que possuem doenças com um polipeptídeo
BR112014026072A2 (pt) método para medir atenção
MX2015008011A (es) Suplementos y sistemas de monitoreo para la dosificacion de los suplementos.
AR088165A1 (es) Proteinas de funcion dual para tratar trastornos metabolicos
WO2015033151A3 (en) Processing system and method
BR112013020041A2 (pt) compostos e métodos para a modulação de quinases, e indicações para os mesmos
BR112015022378A2 (pt) método para identificar uma área de um coração humano, sistema para identificar uma área de um coração humano, método para definir um acionador de uma fonte associada a um distúrbio de ritmo cardíaco de um coração humano, e, sistema para definir um acionador de uma fonte associada a um distúrbio de ritmo cardíaco de um coração humano
BR112014029346A2 (pt) sistema e método implementado por computador para a montagem de um plano de tratamento médico
BR112012018269A2 (pt) sistema e método para testar analito
BR112015026601A2 (pt) método para um ensaio de triagem de fármaco à base de células e o uso do mesmo
BR112015020078A8 (pt) método para aumentar uma experiência de jogo e dispositivo de monitoramento de atividade física
BR112013003160A2 (pt) tratamento de diabetes com células precursoras endócrinas pancráticas
BR112015013046A2 (pt) composição comestível, método de redução da amplitude do pico de glicose pós-prandial no sangue ou resposta glicêmica em uma pessoa diabética ou não diabética, método para tratar uma pessoa em necessidade deste para diabetes tipo 2 e uso de uma composição
BR112012010995A2 (pt) revestimentos e métodos de revestimento de agulhas cirúrgicas
BR112016014876A2 (pt) composto que modula a quantidade ou a atividade de gibspla2, composição farmacêutica, imunógeno que induz uma resposta imune anti-gibspla2, composição de vacina, método para o diagnóstico da imunodeficiência humana associada com a alteração de células t, e, método para a produção de gibspla2

Legal Events

Date Code Title Description
B11A Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing
B11Y Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]